These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 34970273)

  • 1. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
    Ye Z; Shi Y; Lees-Miller SP; Tainer JA
    Front Immunol; 2021; 12():797880. PubMed ID: 34970273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When DNA-damage responses meet innate and adaptive immunity.
    Tong J; Song J; Zhang W; Zhai J; Guan Q; Wang H; Liu G; Zheng C
    Cell Mol Life Sci; 2024 Apr; 81(1):185. PubMed ID: 38630271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfaces between cellular responses to DNA damage and cancer immunotherapy.
    Pilger D; Seymour LW; Jackson SP
    Genes Dev; 2021 May; 35(9-10):602-618. PubMed ID: 33888558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crosstalk between DNA-damage responses and innate immunity.
    He M; Jiang H; Li S; Xue M; Wang H; Zheng C; Tong J
    Int Immunopharmacol; 2024 Oct; 140():112768. PubMed ID: 39088918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Damage and Cancer Immunotherapy: A STING in the Tale.
    Reisländer T; Groelly FJ; Tarsounas M
    Mol Cell; 2020 Oct; 80(1):21-28. PubMed ID: 32810436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complementarity of DDR, nucleic acids and anti-tumour immunity.
    Kornepati AVR; Rogers CM; Sung P; Curiel TJ
    Nature; 2023 Jul; 619(7970):475-486. PubMed ID: 37468584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
    Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
    Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse immune response of DNA damage repair-deficient tumors.
    Qing T; Jun T; Lindblad KE; Lujambio A; Marczyk M; Pusztai L; Huang KL
    Cell Rep Med; 2021 May; 2(5):100276. PubMed ID: 34095878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
    Huang JL; Chang YT; Hong ZY; Lin CS
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.
    Storozynsky Q; Hitt MM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic Acid Immunity and DNA Damage Response: New Friends and Old Foes.
    Taffoni C; Steer A; Marines J; Chamma H; Vila IK; Laguette N
    Front Immunol; 2021; 12():660560. PubMed ID: 33981307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy.
    Xie B; Luo A
    Front Cell Dev Biol; 2022; 10():903781. PubMed ID: 35557952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage response and neoantigens: A favorable target for triple-negative breast cancer immunotherapy and vaccine development.
    Subbarayan R; Srinivasan D; Balakrishnan R; Kumar A; Usmani SS; Srivastava N
    Int Rev Cell Mol Biol; 2024; 389():104-152. PubMed ID: 39396845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication.
    Lamberti G; Andrini E; Sisi M; Federico AD; Ricciuti B
    Future Oncol; 2020 Aug; 16(23):1751-1766. PubMed ID: 32539551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STING: a master regulator in the cancer-immunity cycle.
    Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
    Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity.
    Manolakou T; Verginis P; Boumpas DT
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication Stress, DNA Damage, Inflammatory Cytokines and Innate Immune Response.
    Ragu S; Matos-Rodrigues G; Lopez BS
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32283785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.
    Dai E; Zhu Z; Wahed S; Qu Z; Storkus WJ; Guo ZS
    Mol Cancer; 2021 Dec; 20(1):171. PubMed ID: 34930302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy.
    Xu Y; Nowsheen S; Deng M
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer.
    Ding K; He Y; Wei J; Fu S; Wang J; Chen Z; Zhang H; Qu Y; Liang K; Gong X; Qiu L; Chen D; Xiao B; Du H
    Front Immunol; 2022; 13():943090. PubMed ID: 36081518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.